Instead, sSiglce-9 levels was higher in COPD patients than controls and subsequently enhanced neutrophil ROS and chemotaxis toward IL-8 probably via competitive inhibiting ligands binding to Siglec-9. Here, CXCL8 is linked to chronic obstructive pulmonary disease.